Copyright Reports & Markets. All rights reserved.

Global Venous Thromboembolism Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Venous Thromboembolism Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Deep Venous Thrombosis
      • 1.4.3 Pulmonary Embolism
    • 1.5 Market by Application
      • 1.5.1 Global Venous Thromboembolism Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Venous Thromboembolism Treatment Market Size
    • 2.2 Venous Thromboembolism Treatment Growth Trends by Regions
      • 2.2.1 Venous Thromboembolism Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Venous Thromboembolism Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Venous Thromboembolism Treatment Market Size by by Players
      • 3.1.1 Global Venous Thromboembolism Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Venous Thromboembolism Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Venous Thromboembolism Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Venous Thromboembolism Treatment Key Players Head office and Area Served
    • 3.3 Key Players Venous Thromboembolism Treatment Product/Solution/Service
    • 3.4 Date of Enter into Venous Thromboembolism Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Venous Thromboembolism Treatment Market Size by Type (2014-2019)
    • 4.2 Global Venous Thromboembolism Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Venous Thromboembolism Treatment Market Size (2014-2019)
    • 5.2 Venous Thromboembolism Treatment Key Players in United States
    • 5.3 United States Venous Thromboembolism Treatment Market Size by Type
    • 5.4 United States Venous Thromboembolism Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Venous Thromboembolism Treatment Market Size (2014-2019)
    • 6.2 Venous Thromboembolism Treatment Key Players in Europe
    • 6.3 Europe Venous Thromboembolism Treatment Market Size by Type
    • 6.4 Europe Venous Thromboembolism Treatment Market Size by Application

    7 China

    • 7.1 China Venous Thromboembolism Treatment Market Size (2014-2019)
    • 7.2 Venous Thromboembolism Treatment Key Players in China
    • 7.3 China Venous Thromboembolism Treatment Market Size by Type
    • 7.4 China Venous Thromboembolism Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Venous Thromboembolism Treatment Market Size (2014-2019)
    • 8.2 Venous Thromboembolism Treatment Key Players in Japan
    • 8.3 Japan Venous Thromboembolism Treatment Market Size by Type
    • 8.4 Japan Venous Thromboembolism Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Venous Thromboembolism Treatment Market Size (2014-2019)
    • 9.2 Venous Thromboembolism Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Venous Thromboembolism Treatment Market Size by Type
    • 9.4 Southeast Asia Venous Thromboembolism Treatment Market Size by Application

    10 India

    • 10.1 India Venous Thromboembolism Treatment Market Size (2014-2019)
    • 10.2 Venous Thromboembolism Treatment Key Players in India
    • 10.3 India Venous Thromboembolism Treatment Market Size by Type
    • 10.4 India Venous Thromboembolism Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Venous Thromboembolism Treatment Market Size (2014-2019)
    • 11.2 Venous Thromboembolism Treatment Key Players in Central & South America
    • 11.3 Central & South America Venous Thromboembolism Treatment Market Size by Type
    • 11.4 Central & South America Venous Thromboembolism Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Medtronic
      • 12.1.1 Medtronic Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Venous Thromboembolism Treatment Introduction
      • 12.1.4 Medtronic Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.1.5 Medtronic Recent Development
    • 12.2 Boston Scientific
      • 12.2.1 Boston Scientific Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Venous Thromboembolism Treatment Introduction
      • 12.2.4 Boston Scientific Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.2.5 Boston Scientific Recent Development
    • 12.3 Stryker
      • 12.3.1 Stryker Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Venous Thromboembolism Treatment Introduction
      • 12.3.4 Stryker Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.3.5 Stryker Recent Development
    • 12.4 AngioDynamics
      • 12.4.1 AngioDynamics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Venous Thromboembolism Treatment Introduction
      • 12.4.4 AngioDynamics Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.4.5 AngioDynamics Recent Development
    • 12.5 Cook Medical
      • 12.5.1 Cook Medical Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Venous Thromboembolism Treatment Introduction
      • 12.5.4 Cook Medical Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.5.5 Cook Medical Recent Development
    • 12.6 Cardinal Health
      • 12.6.1 Cardinal Health Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Venous Thromboembolism Treatment Introduction
      • 12.6.4 Cardinal Health Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.6.5 Cardinal Health Recent Development
    • 12.7 DJO Global
      • 12.7.1 DJO Global Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Venous Thromboembolism Treatment Introduction
      • 12.7.4 DJO Global Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.7.5 DJO Global Recent Development
    • 12.8 Philips Holding
      • 12.8.1 Philips Holding Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Venous Thromboembolism Treatment Introduction
      • 12.8.4 Philips Holding Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.8.5 Philips Holding Recent Development
    • 12.9 ArjoHuntleigh AB
      • 12.9.1 ArjoHuntleigh AB Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Venous Thromboembolism Treatment Introduction
      • 12.9.4 ArjoHuntleigh AB Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.9.5 ArjoHuntleigh AB Recent Development
    • 12.10 Argon Medical Devices
      • 12.10.1 Argon Medical Devices Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Venous Thromboembolism Treatment Introduction
      • 12.10.4 Argon Medical Devices Revenue in Venous Thromboembolism Treatment Business (2014-2019)
      • 12.10.5 Argon Medical Devices Recent Development
    • 12.11 DaeSung Maref
    • 12.12 ALN Implants Chirurgicaux
    • 12.13 Lifetech Scientific

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      A venous thrombus is a blood clot (thrombus) that forms within a vein. Thrombosis is a term for a blood clot occurring inside a blood vessel. A common type of venous thrombosis is a deep vein thrombosis (DVT), which is a blood clot in the deep veins of the leg. If the thrombus breaks off (embolizes) and flows towards the lungs, it can become a pulmonary embolism (PE), a blood clot in the lungs.
      In 2018, the global Venous Thromboembolism Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Venous Thromboembolism Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Venous Thromboembolism Treatment development in United States, Europe and China.

      The key players covered in this study
      Medtronic
      Boston Scientific
      Stryker
      AngioDynamics
      Cook Medical
      Cardinal Health
      DJO Global
      Philips Holding
      ArjoHuntleigh AB
      Argon Medical Devices
      DaeSung Maref
      ALN Implants Chirurgicaux
      Lifetech Scientific

      Market segment by Type, the product can be split into
      Deep Venous Thrombosis
      Pulmonary Embolism

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Venous Thromboembolism Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Venous Thromboembolism Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Venous Thromboembolism Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now